ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) announced the Company's supplemental New Drug Application (sNDA) for once-daily XiDay™ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE